At AstraZeneca, this role as US Medical Head, COPD Biologics, involves combining scientific depth with strategic leadership to advance care in chronic respiratory disease. The position owns the medical strategy and execution for a novel Interleukin-33 targeting monoclonal antibody, crafting both product and disease area direction across the full lifecycle. Reporting directly to the VP Medical Respiratory, Immunology, Vaccines and Immune Therapies (R&I), this leader will guide a high-performing team, drive launches, and influence how evidence, access and clinical practice come together to transform outcomes for patients living with COPD and severe lower respiratory tract disease. AstraZeneca offers an environment where medical leaders sit at the intersection of science and real-world practice, using evidence to influence how care is delivered today and tomorrow. Collaboration across research, medical and commercial functions is embedded, opening doors to new ideas, broader networks and continuous development without borders. Every study designed, every partnership built and every insight translated into practice contributes directly to better outcomes for patients and fuels the next wave of scientific progress.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees